Stay updated on Alteplase in Mild Stroke: Efficacy Clinical Trial
Sign up to get notified when there's something new on the Alteplase in Mild Stroke: Efficacy Clinical Trial page.

Latest updates to the Alteplase in Mild Stroke: Efficacy Clinical Trial page
- Check2 days agoChange DetectedThe PRISMS study record is displayed with its trial details, participant criteria, treatment plan, outcome measures, locations, and study documents. The prior error page and NIH announcement banner are no longer shown.SummaryDifference94%

- Check9 days agoChange DetectedThe site footer now identifies the platform revision as v3.8.0 instead of v3.7.2; the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA notice about NIH website changes and the use of “Super Intelligence” terminology appears above the inaccessible study record.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0; the page continues to show a 403 error.SummaryDifference0.2%

- Check51 days agoChange DetectedAccess to the study record now results in a 403 Forbidden page, so the study details are not accessible. This indicates an access restriction or server-side issue rather than an update to the study content.SummaryDifference18%

Stay in the know with updates to Alteplase in Mild Stroke: Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alteplase in Mild Stroke: Efficacy Clinical Trial page.